LIF
Life360, Inc.
41.30$
+1.3%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +1.7% | -0.9% | +27.3% | +5.3% | +3.3% | +3.1% | +65.5% | +4.5% | +21.9% | +8.5% | +1.1% | |
| – | +5.2% | +0.0% | +66.2% | +7.8% | +2.4% | +3.8% | +108.4% | +6.9% | +8.8% | -2.7% | +1.6% | |
| – | +11.5% | +6.4% | +119.1% | -1.1% | +0.2% | +6.0% | +156.3% | +5.3% | +8.5% | -28.9% | -24.0% | |
| – | +11.5% | +6.4% | +119.1% | -1.1% | +0.2% | +6.0% | +156.3% | +5.3% | +8.5% | -7.5% | +1.7% | |
| – | +5.6% | -12.4% | +9.4% | +21.4% | +23.5% | -9.7% | +12.8% | +10.9% | +19.3% | +16.5% | +2.0% | |
| – | -62.5% | +54.6% | -12.5% | +148.7% | -41.6% | +18.8% | +1.1% | +46.1% | -30.2% | +53.5% | -2.9% | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.7% | +0.0% | +0.0% | +0.0% | +29.0% | +0.0% | |
| – | -3.7% | -2.6% | -1.7% | -2.9% | -4.0% | +6.1% | -1.2% | -5.9% | -4.3% | +113.3% | -5.1% | |
| – | -1.9% | +5.7% | +0.4% | +10.7% | -5.3% | -4.7% | +388.9% | +2.3% | +3.9% | +7.7% | -1.1% | |
| – | -2.6% | +4.5% | +4.9% | +9.8% | -9.3% | -4.3% | -1.5% | +12.3% | +18.1% | +13.5% | -2.6% | |
| – | -3.8% | +16.3% | -92.1% | +2.0% | +2.2% | +1.9% | +2.2% | +1.8% | -7.0% | – | – | |
| – | -54.3% | +59.2% | +6.8% | +90.3% | -71.4% | -4.6% | -43.1% | +199.8% | -5.4% | +161.2% | -29.2% | |
| – | +11.2% | +9.9% | – | – | – | – | – | +0.2% | +0.2% | +0.2% | +0.2% | |
| – | +2.8% | -2.9% | +36.2% | +4.0% | +5.6% | +4.9% | -2.6% | +6.8% | +40.0% | +9.0% | +2.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1.6% | +0.6% | +3.2% | +16.0% | +1.4% | +0.3% | +1.2% | +1.6% | -0.7% | +0.6% | -0.1% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.